The industry’s intellectual capital will be rearranged in the coming years, as US$25bn worth of patents expire. The road to market for new products is passing through rough terrain.
Yet the rewards for success have never been greater. Emerging technologies promise to vanquish diseases once thought ineradicable. Ageing populations in developed countries, and the emerging middle class in developing ones, represent enormous opportunities. Those who can bring the solutions to market first stand to lead the industry for years to come.
Kerry stands ready to support you on your product development journey. We have world-beating service and facilities to support you, from your product’s design, to its launch, and beyond. Our success is built on the relationships we have with manufacturers. Our drive to innovate is aligned with your needs.
Kerry, through the Sheffield brand, has been at the forefront of pharmaceutical excipient and cell nutrition innovation for more than 75 years. We come from humble beginnings as a lactose producer in up-state New York, but our culture of technical excellence and passion for breaking new ground have seen us grow year-on-year.
Today we are a global presence, with laboratories in Asia, the Middle East, Europe, and the Americas. Six of the world’s top 10 blockbuster biotech drugs—those that have generated more than US$1bn in revenues—are produced with Sheffield-branded components in their production media. Around a quarter of all biotech drugs on the market use our products, and our research has been cited in more the 700 peer-reviewed scientific articles. Sheffield-branded ingredients are also found in many pathogenic and viral vaccine production media, and vaccine stabilisers and adjuvants.
The industry has recognised our work in a series of awards:
Get it right the first time, with Kerry.
Get an insider perspective on food and beverage insights and innovations.